BMY Stock
Bristol-Myers Squibb Co.
$58.83
+0.00% today
YTD +9.0%
Price
Daily closes via Alpaca (IEX); today's point is the latest trade.
Key stats
52-week range
$47.76
$68.64
Valuation
P/E (trailing)13.2
Forward P/E9.5
Price / sales2.4
Price / book5.4
EPS (12 mo)$4.51
Dividend yield4.58%
Beta0.17
Financial health last 12 months
Revenue growth+4.2%
Earnings growth+52.4%
Gross margin70.5%
Net margin+18.5%
Return on equity43.9%
Debt / equity1.83
Hover a figure for what it means.
Analyst ratings Nov 2026 · 34 analysts
Consensus: Buy
Strong buy 6Buy 8
Hold 19Sell 1
Strong sell 0
| Month | Buy | Hold | Sell | Consensus |
|---|---|---|---|---|
| Nov 2026 | 14 | 19 | 1 | Buy |
| Oct 2026 | 15 | 18 | 1 | Buy |
| Sep 2026 | 15 | 18 | 2 | Buy |
| Aug 2026 | 14 | 19 | 2 | Buy |
Latest news
Bristol Myers Squibb's Growth Portfolio Just Hit $7.7 Billion. Is This Cheap Pharma Stock a No-Brainer Buy?
Yahoo · 1d ago
Erasca: 'Buy' On Expanded KRAS Targeting ERAS-4001 And Bristol-Myers Squibb Collaboration Tie-Up
SeekingAlpha · 1d ago
3 Big Pharma Dividend Stocks Built for Retirement Income
Yahoo · 2d ago
Headlines from the last 10 days via Finnhub; links open the publisher's article.
Next earnings
No report scheduled in the next 4 months.
Past earnings moves
No tracked reports yet. TradeSphere saves the expected and actual move for every report from Nov 3, 2026 on, for stocks on the Earnings page.